A little slower. We were doing well. The U.S. times have sped up, and they're now committed to moving faster.
The other area to consider, Mr. Chair, is the emerging areas of CRISPR and Cas9. How are those going to be regulated in the United States, and how are they going to be regulated in Canada? Innovation is moving at an incredibly fast pace, and how Canada reacts to that is going to be critical.